← Back to Search

Soft Contact Lenses

KeraSoft IC Soft Contact Lenses for Keratoconus

N/A
Waitlist Available
Research Sponsored by Bausch & Lomb Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 visits over 1 year
Awards & highlights

Summary

The objective of this twelve month dispensing study is to evaluate the clinical performance, particularly comfort and vision, of KeraSoft IC Soft Contact Lenses.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 visits over 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 visits over 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Comfort
Secondary outcome measures
Visual Acuity - High Contrast
Visual Acuity - Low Contrast

Trial Design

1Treatment groups
Experimental Treatment
Group I: KeraSoft IC Soft Contact LensesExperimental Treatment1 Intervention
KeraSoft IC Soft Contact Lenses, with CIBA Clear Care solution provided for lens care

Find a Location

Who is running the clinical trial?

Bausch & Lomb IncorporatedLead Sponsor
252 Previous Clinical Trials
57,325 Total Patients Enrolled
2 Trials studying Keratoconus
53 Patients Enrolled for Keratoconus
Robert Steffen, OD, MSStudy DirectorBausch & Lomb Incorporated
5 Previous Clinical Trials
323 Total Patients Enrolled
~1 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top